Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. This segment offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. It also provides proprietary and joint industry studies. The Production Enhancement segment includes services and products relating to reservoir well completions, perforations, stimulations, and production. This segment offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
SectorOils/Energy
SymbolNYSE:CLB
CUSIPN/A
Phone31-20-420-3191
Debt
Debt-to-Equity Ratio1.53
Current Ratio2.24
Quick Ratio1.85
Price-To-Earnings
Trailing P/E Ratio51.89
Forward P/E Ratio43.42
P/E Growth3.72
Sales & Book Value
Annual Sales$659.81 million
Price / Sales6.95
Cash Flow$2.4951 per share
Price / Cash41.59
Book Value$3.37 per share
Price / Book30.79
Profitability
EPS (Most Recent Fiscal Year)$2.00
Net Income$83.12 million
Net Margins13.32%
Return on Equity64.13%
Return on Assets16.55%
Miscellaneous
Employees4,600
Outstanding Shares44,210,000
Market Cap$4.72 billion
Core Laboratories (NYSE:CLB) Frequently Asked Questions
What is Core Laboratories' stock symbol?
Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."
How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?
Core Laboratories announced a quarterly dividend on Tuesday, October 9th. Shareholders of record on Friday, October 19th will be paid a dividend of $0.55 per share on Tuesday, November 20th. This represents a $2.20 annualized dividend and a yield of 2.12%. The ex-dividend date of this dividend is Thursday, October 18th. View Core Laboratories' Dividend History.
How were Core Laboratories' earnings last quarter?
Core Laboratories (NYSE:CLB) announced its quarterly earnings data on Wednesday, July, 25th. The oil and gas company reported $0.59 EPS for the quarter, meeting analysts' consensus estimates of $0.59. The oil and gas company had revenue of $175.48 million for the quarter, compared to analyst estimates of $174.47 million. Core Laboratories had a net margin of 13.32% and a return on equity of 64.13%. The company's revenue was up 10.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.51 earnings per share. View Core Laboratories' Earnings History.
When is Core Laboratories' next earnings date?
How can I listen to Core Laboratories' earnings call?
Core Laboratories will be holding an earnings conference call on Thursday, October 25th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.
What guidance has Core Laboratories issued on next quarter's earnings?
Core Laboratories updated its third quarter earnings guidance on Wednesday, July, 25th. The company provided earnings per share guidance of $0.64-0.66 for the period, compared to the Thomson Reuters consensus estimate of $0.65. The company issued revenue guidance of $177-179 million, compared to the consensus revenue estimate of $178.49 million.
What price target have analysts set for CLB?
16 brokerages have issued 12 month price targets for Core Laboratories' stock. Their predictions range from $95.00 to $136.00. On average, they anticipate Core Laboratories' stock price to reach $113.3283 in the next year. This suggests a possible upside of 9.2% from the stock's current price. View Analyst Price Targets for Core Laboratories.
What is the consensus analysts' recommendation for Core Laboratories?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings, 9 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.
Who are some of Core Laboratories' key competitors?
Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), RPC (RES), Oceaneering International (OII), Liberty Oilfield Services (LBRT), Franks International (FI), SemGroup (SEMG), Helix Energy Solutions Group (HLX), Superior Energy Services (SPN), C&J Energy Services (CJ), Keane Group (FRAC), FTS International (FTSI), Mammoth Energy Services (TUSK), Select Energy Services (WTTR), National Energy Services (NESR) and Hurricane Energy (HRCXF).
Who are Core Laboratories' key executives?
Core Laboratories' management team includes the folowing people:
- Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 63)
- Mr. Monty L. Davis, Chief Operating Officer and Sr. VP (Age 64)
- Mr. Richard L. Bergmark, Exec. VP (Age 65)
- Mr. Lawrence V. Bruno, Pres & Supervisory Director (Age 58)
- Mr. Christopher Scott Hill, Sr. VP & CFO (Age 48)
Who are Core Laboratories' major shareholders?
Core Laboratories' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Franklin Street Advisors Inc. NC (0.18%), Gofen & Glossberg LLC IL (0.13%), Douglas Lane & Associates LLC (0.06%), Bank of Montreal Can (0.06%), Manning & Napier Group LLC (0.05%) and Aperio Group LLC (0.05%). Company insiders that own Core Laboratories stock include Kevin Daniels, Martha Z Carnes and Michael Straughen. View Institutional Ownership Trends for Core Laboratories.
Which institutional investors are selling Core Laboratories stock?
Which institutional investors are buying Core Laboratories stock?
CLB stock was bought by a variety of institutional investors in the last quarter, including Douglas Lane & Associates LLC, Personal Capital Advisors Corp, Forte Capital LLC ADV, Welch & Forbes LLC, Aperio Group LLC and First Citizens Bank & Trust Co.. Company insiders that have bought Core Laboratories stock in the last two years include Martha Z Carnes and Michael Straughen. View Insider Buying and Selling for Core Laboratories.
How do I buy shares of Core Laboratories?
Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Core Laboratories' stock price today?
One share of CLB stock can currently be purchased for approximately $103.77.
How big of a company is Core Laboratories?
Core Laboratories has a market capitalization of $4.72 billion and generates $659.81 million in revenue each year. The oil and gas company earns $83.12 million in net income (profit) each year or $2.00 on an earnings per share basis. Core Laboratories employs 4,600 workers across the globe.
What is Core Laboratories' official website?
How can I contact Core Laboratories?
Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]
MarketBeat Community Rating for Core Laboratories (NYSE CLB)
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
